Pörssitiedote13.11.2024 klo 16.15Bio Vitos Pharma AB (publ) appoints LAGO KAPITAL as liquidity provider
Pörssitiedote12.02.2024 klo 14.50Bio Vitos Pharma AB: KFUM Kalmar and Bio Vitos Pharma enter into an agreement regarding a research study on Succifer
Pörssitiedote20.12.2023 klo 08.30Bio Vitos Pharma AB: The European Patent Office EPO grants patent that is important to Bio Vitos Pharma
Pörssitiedote04.05.2023 klo 15.00Hemcheck submits a formal application to Nasdaq for a decision on continued listing before the implementation of the Bio Vitos agreement
Pörssitiedote26.04.2023 klo 17.20Hemcheck: Additional follow up order from the Foundation for Innovative New Diagnostics (FIND)
Pörssitiedote05.04.2023 klo 23.50Hemcheck has received a first order from the university hospital Charité in Berlin
Pörssitiedote16.03.2023 klo 14.10Hemcheck: Additional agreement with Bio Vitos Medical brings forward the time for calling the extraordinary general meeting by one week
Pörssitiedote13.03.2023 klo 18.00Hemcheck has received a first follow up order from its Finnish distributor
Pörssitiedote02.03.2023 klo 18.00Hemcheck has received an additional follow up order from its UK distributor
Pörssitiedote28.02.2023 klo 22.15Hemcheck receives follow up order from research program in the United States
Pörssitiedote24.01.2023 klo 18.00Hemcheck has received a first order from a leading hospital in Iceland
Pörssitiedote23.01.2023 klo 12.00Hemcheck has received a follow up order from its Spanish distributor
Pörssitiedote16.01.2023 klo 23.30Hemcheck has received another follow up order from its Irish distributor
Pörssitiedote03.01.2023 klo 18.27Hemcheck extends agreement regarding previously communicated project with Region Skåne